A carregar...

Melatonin and Bright-Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer’s Disease

OBJECTIVES: To test whether the addition of melatonin to bright-light therapy enhances the efficacy in treating rest–activity (circadian) disruption in institutionalized patients with Alzheimer’s disease (AD). DESIGN: Randomized, controlled trial. SETTING: Two nursing homes in San Francisco, Califor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dowling, Glenna A., Burr, Robert L., Van Someren, Eus J. W., Hubbard, Erin M., Luxenberg, Jay S., Mastick, Judy, Cooper, Bruce A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2642966/
https://ncbi.nlm.nih.gov/pubmed/18070004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1532-5415.2007.01543.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!